OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors
Publication
, Conference
Falchook, G; Li, BT; Marrone, KA; Bestvina, CM; Langer, CJ; Krauss, JC; Strickler, JH; Meloni, A; Dai, T; Varrieur, T; Hong, DS
Published in: Journal of Thoracic Oncology
September 2022
Duke Scholars
Published In
Journal of Thoracic Oncology
DOI
ISSN
1556-0864
Publication Date
September 2022
Volume
17
Issue
9
Start / End Page
S8 / S8
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Falchook, G., Li, B. T., Marrone, K. A., Bestvina, C. M., Langer, C. J., Krauss, J. C., … Hong, D. S. (2022). OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors. In Journal of Thoracic Oncology (Vol. 17, pp. S8–S8). Elsevier BV. https://doi.org/10.1016/j.jtho.2022.07.022
Falchook, G., B. T. Li, K. A. Marrone, C. M. Bestvina, C. J. Langer, J. C. Krauss, J. H. Strickler, et al. “OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors.” In Journal of Thoracic Oncology, 17:S8–S8. Elsevier BV, 2022. https://doi.org/10.1016/j.jtho.2022.07.022.
Falchook G, Li BT, Marrone KA, Bestvina CM, Langer CJ, Krauss JC, et al. OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors. In: Journal of Thoracic Oncology. Elsevier BV; 2022. p. S8–S8.
Falchook, G., et al. “OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors.” Journal of Thoracic Oncology, vol. 17, no. 9, Elsevier BV, 2022, pp. S8–S8. Crossref, doi:10.1016/j.jtho.2022.07.022.
Falchook G, Li BT, Marrone KA, Bestvina CM, Langer CJ, Krauss JC, Strickler JH, Meloni A, Dai T, Varrieur T, Hong DS. OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors. Journal of Thoracic Oncology. Elsevier BV; 2022. p. S8–S8.
Published In
Journal of Thoracic Oncology
DOI
ISSN
1556-0864
Publication Date
September 2022
Volume
17
Issue
9
Start / End Page
S8 / S8
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology